A Study of Baricitinib (LY3009104) in Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT03334396 · COMPLETED
Trial details
- NCT number
- NCT03334396
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-23
- Primary completion
- 2018-12-06
- Enrollment
- 660
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.